When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADAP - Adaptimmune's SPEAR T-cell platform delivers initial responses in four solid tumors; shares up 60% premarket
Adaptimmune Therapeutics plc
Adaptimmune Therapeutics (NASDAQ:ADAP) is up 60% premarket after reporting two confirmed Partial Responses (PRs) – one in a patient with liver cancer and one in a patient with melanoma.
More news on: Adaptimmune Therapeutics plc, Healthcare stocks news, Stocks on the move,